Your browser doesn't support javascript.
loading
Success of Big Infectious Disease Reimbursement Policy in China.
Nie, Kun-Xi; Wang, Chan; Li, Xin-Wu.
Affiliation
  • Nie KX; Shihezi University, Guangzhou, P.R. China.
  • Wang C; Guangdong University of Finance & Economics, Guangzhou, P.R. China.
  • Li XW; Guangdong University of Finance & Economics, Guangzhou, P.R. China.
Inquiry ; 57: 46958020907788, 2020.
Article in En | MEDLINE | ID: mdl-32075479
Big infectious diseases do harm to the whole society, and it is highly crucial to control them on time. The major purpose of this article is to theoretically demonstrate that the Chinese government's intervention in large-scale infectious diseases is successful and efficient. Two potential strategies were considered: strategy 1 was infectious disease without government intervention, and strategy 2 was infectious disease with government intervention. By evolution model, this article illustrates the efficiency of big infectious disease reimbursement policy in China. Without government reimbursement, this article finds that high expenditures accelerate the disease infection. The number of infected persons decreases under big infectious disease reimbursement policy in China. The higher the treatment costs, the more important the government intervention. Big infectious disease reimbursement policy in China can serve as an efficient example to cope with big infectious diseases.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reimbursement Mechanisms / Communicable Diseases / Infection Control / Health Expenditures Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Inquiry Year: 2020 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reimbursement Mechanisms / Communicable Diseases / Infection Control / Health Expenditures Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Inquiry Year: 2020 Document type: Article Country of publication: